IHS Chemical Week

World News and Views :: Top of the News

EFCG Ratifies FDA's Proposed Generic Drug User Fees Act

6:01 AM MDT | September 13, 2011 | Deepti Ramesh

The European Fine Chemicals Group (EFCG; Brussels) says its board has agreed to ratify the proposal of the U.S. Food and Drug Administration (FDA) to put forward a legislative package, designed with the help of EFCG and U.S. industry representatives, to deliver into U.S. law, a new generic drug user fees act (GDUFA). GDUFA requires the FDA to commit to significantly improve its regulatory activities for the benefit of global generic drug providers and U.S. generic drug users, in exchange for the global generics industry providing FDA with $299 million in user...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa